Dividend Logo Green Small
MENU
Advertisement.

NMRA:Neumora Therapeutics Inc - Stock Price Quote and Dividend Data

NMRA STOCK PRICE LATEST CLOSE

$0.72

EXCHANGE

NASDAQ

NMRA

Neumora Therapeutics Inc Dividend Information

Projected 12 Month Dividend Yield0.00%
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeN/A
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
NMRA

Neumora Therapeutics Inc Stock Price Information

NMRA Stock Price Latest Close$0.72
52-Week Low/High Stock Price$0.62 - $17.19
Percent Held by Institutions42.90%
Revenue$0
Net Income$-302,606,000
Cash Flow$-233,276,000
EPS-0.37%
Market Cap$116,074,151
Issue TypeCommon, ordinary, ADR, etc.
PE Ratio0
PE Ratio to Industry40%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.42%
Total Return Last 12 Months-95.12%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateApr. 10, 2025
NMRA

Neumora Therapeutics Inc Annual Stock Dividends

No Data available for Payment History.

NMRA

Neumora Therapeutics Inc Dividend Payment History

No dividends retrieved for NMRA
NMRA

Neumora Therapeutics Inc Other Dividend Details

Neumora Therapeutics is a clinical-stage biopharmaceutical company. Co. has scaled its therapeutic pipeline, which consists of seven clinical and preclinical neuroscience programs that target mechanisms of action for a range of neuropsychiatric disorders and neurodegenerative diseases. Co.'s primary product candidate, navacaprant (NMRA-140), is a once-daily oral kappa opioid receptor antagonist that is being developed for the treatment of major depressive disorder (MDD). Co. is initiating a Phase 3 program for navacaprant monotherapy in patients with moderate to severe MDD.

Web Sitewww.neumoratx.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Neumora Therapeutics Inc Dividend Stock News and Updates

Apr. 05, 2025NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 04-05-2025 decreased stock price > 10% from $0.85 to $0.74

Mar. 11, 2025NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 03-11-2025 decreased stock price > 10% from $1.49 to $1.34

Feb. 28, 2025NMRA STOCK PRICE 52 WEEK LOW: Neumora Therapeutics Inc on 02-28-2025 hit a 52 week low of $1.55

Jan. 07, 2025NMRA STOCK PRICE INCREASE: Neumora Therapeutics Inc on 01-07-2025 increased stock price > 10% from $2.17 to $2.48

Jan. 04, 2025NMRA STOCK PRICE INCREASE: Neumora Therapeutics Inc on 01-04-2025 increased stock price > 10% from $1.97 to $2.17

Jan. 03, 2025NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 01-03-2025 decreased stock price > 10% from $10.60 to $1.97

Nov. 13, 2024NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 11-13-2024 decreased stock price > 10% from $13.64 to $11.31

Oct. 22, 2024NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 10-22-2024 decreased stock price > 10% from $16.49 to $14.05

Apr. 16, 2024NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 04-16-2024 decreased stock price > 10% from $13.56 to $11.19

Mar. 14, 2024NMRA STOCK PRICE DECREASE: Neumora Therapeutics Inc on 03-14-2024 decreased stock price > 10% from $17.35 to $14.81

More Neumora Therapeutics Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00

Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66

Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08

Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06

Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94

Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20

Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12

Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05

Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83

Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13

More Pharmaceuticals Dividend News
X
Search Dividend Investor